• OPEN AN ACCOUNT
Indian Indices
Sensex
74,003.82 -777.94
( -1.04%)
Global Indices
Nasdaq
52,442.46 -151.83
(-0.29%)
Dow Jones
7,640.91 -37.07
(-0.48%)
Hang Seng
63,634.18 141.19
(0.22%)
Nikkei 225
10,654.59 -42.98
(-0.40%)
Forex
USD-INR
95.47 0.03
(0.03%)
EUR-INR
110.72 -0.23
(-0.20%)
GBP-INR
129.12 -0.04
(-0.03%)
JPY-INR
0.62 0.00
(0.29%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

vivanza biosciences ltd
Consecutive Commodities standalone net profit rises 60.00% in the March 2026 quarter
May 26,2026
Net profit of Consecutive Commodities rose 60.00% to Rs 0.88 crore in the quarter ended March 2026 as against Rs 0.55 crore during the previous quarter ended March 2025. Sales rose 7.82% to Rs 16.40 crore in the quarter ended March 2026 as against Rs 15.21 crore during the previous quarter ended March 2025.

For the full year,net profit rose 21.08% to Rs 2.70 crore in the year ended March 2026 as against Rs 2.23 crore during the previous year ended March 2025. Sales rose 156.11% to Rs 57.88 crore in the year ended March 2026 as against Rs 22.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales16.4015.21 8 57.8822.60 156
OPM %4.94-0.66 -5.305.09 -
PBDT0.820.07 1071 3.282.32 41
PBT0.820.07 1071 3.282.32 41
NP0.880.55 60 2.702.23 21